IDXG — Interpace Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Interpace Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	R2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	2.77	3.06	4.83	3.5	1.46
Net Total Accounts Receivable
Net Total Receivables	8.03	6.16	5.03	5.08	8.54
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	14.1	12.2	12.2	10.4	11.8
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	11.7	10.4	2.92	2.65	2.97
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	45.7	38.4	16	13.1	14.8
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	18.2	15.7	14.3	11.4	10.6
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	28.2	34.3	32.5	22.1	17
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	17.5	4.12	-16.5	-9	-2.22
Total Liabilities & Shareholders' Equity	45.7	38.4	16	13.1	14.8
Total Common Shares Outstanding
Total Preferred Shares Outstanding